Steve's note: Before we get to today's essay, I want to make sure you know about my latest project. You see, I've put the majority of my investable net worth in real estate... And I've done well over the years. Now, we're getting a major opportunity in this sector.

So on Wednesday, June 24, at 8 p.m. Eastern time, I'm holding a special event online to share the details... and to go public with the secrets that have helped me profit in real estate. You can sign up to watch right here.

The Five-Step Formula for Buying Winning Stocks

By Dr. David Eifrig, editor, Retirement Millionaire

I hear folks say this all the time... "I wish there was a magic formula for investing."

It turns out, there is.

Joel Greenblatt, a hedge-fund manager and professor at Columbia University, came up with a "magic formula" investing strategy and shared it with the world in his 2005 bestselling book, The Little Book That Beats the Market. He continued sharing it in his follow-up book in 2010, The Little Book That Still Beats the Market.

This formula was magic because according to Greenblatt's testing, the strategy averaged 24% returns per year from 1988 to 2009. That's more than double the annual return from the broader market over the same stretch.

Greenblatt's magic formula focuses on screening for companies that fit specific criteria and uses a methodical, unemotional process to invest over time.

You set the guidelines and buy whatever stocks are at the top of that list. You just follow the rules. It's investing made easy.

I have my own set of criteria when I look for investment ideas. If you follow these five guidelines in your own investing, you'll sleep well at night... and make money in the process.

Here's my formula for buying winning stocks...

Back in late 2018, I wrote about two consumer staple stocks: spice maker McCormick (MKC) and condiment giant Kraft Heinz (KHC). At the time, these two stocks looked attractive. Both had products with incredible brand loyalty. And both were cheap.

But there was one major difference between both companies... One consistently grew its revenues over the past three decades. The other did not.

I'll let you guess which stock had consistent top-line growth and which one didn't...

McCormick was the big winner. And that showed in its returns. If a company is struggling to increase its sales, why would you want to own it?

I like seeing a company that has multiple years of consecutive revenue growth.

You want to buy companies that don't have to spend a lot of money to make a lot of money.

These are companies that are highly profitable and can return money back to shareholders.

One way to find these efficient companies is by looking at something called return on assets ("ROA").

The formula for ROA is net income divided by total assets. The higher that number, the better a company's management team is at using its assets to generate income. The average company in the S&P 500 Index has a ROA around 2.7%.

I like seeing a company that has a ROA of at least 10%.

If I'm looking for an investment idea, I always check out the list of Dividend Aristocrats. These are S&P 500 companies that have increased their dividends for 25 consecutive years or more. You can find the list of current Dividend Aristocrats here.

No matter what a company does, whether it sells tools, clothes, or soda... if it can raise its dividend payments each year for a quarter of a century, it's a high-quality business. Period.

You know that the management team has done a lot of things right over the years and you know the company is profitable.

There are, however, only 66 Dividend Aristocrats currently. It's an exclusive club to be in. For more ideas, I check out the list of Dividend Achievers – a broader list that includes companies which have increased their dividend for 10 or more consecutive years. You can find that list here.

And it's important to own a dividend-paying stock because over the past 90-plus years, dividends were responsible for roughly 40% of the total market return. If you want long-term success in the market, own high-quality dividend payers.

I like seeing a company with at least 10 or more consecutive years of dividend growth.

You want to stay away from companies that are highly in debt. They're the first dominoes to fall in times of crisis.

To measure this, we look at a company's net debt (total debt minus cash) to earnings before interest, depreciation, and amortization ("EBITDA"). We use EBITDA because it's often used as a shortcut to estimate the cash flow available to pay off debt.

The net debt-to-EBITDA ratio shows how long it would take for a company to pay back its debt. The higher the ratio, the less likely a company is to handle its debt burden... And the less likely it is to take on more debt to grow the business. We want to own companies with strong balance sheets.

I like seeing a company that has a net debt-to-EBITDA of less than 4.

We all know quality comes at a price... And if you overpay for a great business – even one that grows revenues, raises dividends, is efficient, and has a strong balance sheet – you can lose money. Price matters.

You can use the basic price-to-earnings ratio to get a sense of a stock's valuation. Right now, the S&P 500 trades for about 22 times earnings.

In general, I want to own stocks that trade for less than the overall market. But again, we're looking at some of the highest-quality companies in the world, so we can expect a bit of a premium valuation.

I like seeing a company that has a price-to-earnings multiple of less than 25.

The more stocks you own that meet these five requirements, the more success you'll likely achieve in the market.

Here's to your health, wealth, and a great retirement,

Dr. David Eifrig

INSIDE TODAY'S
DailyWealth Premium

A leader in the finance industry with strong profit margins...

A handful of metrics can tell you when a company is superior to the rest. And this bank's ability to generate profits is among the best in its industry...

Market Notes

COVID-19 TESTS ARE IN HIGH DEMAND TODAY

Today's company profits during the fight against COVID-19...

The coronavirus sparked unprecedented and economically devastating shutdowns. Everyone is eager to open as soon as it's safe to do so. To make that determination, officials need lots of valid test results. And this company is a leading authorized supplier...

Danaher (DHR) is $125 billion manufacturing conglomerate specializing in health and science. One of Danaher's many subsidiaries, Cepheid, won government approval for a coronavirus test that provides a result in about 45 minutes. Cepheid's test uses proprietary equipment that 5,000 U.S. hospitals already own. And as Forbes recently reported, Danaher's size and diversified holdings made it easy to produce lots of tests quickly.

As the chart shows, this company's success goes beyond COVID-19 testing... DHR shares have doubled over the past three years, and they recently hit a new all-time high. Danaher's advanced products are always in demand, and its swift response to the coronavirus just gave it another tailwind...

Tell us what you think of this content

We value our subscribers’ feedback. To help us improve your experience, we’d like to ask you a couple brief questions.